Imbalanced IL10/TGF-β production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis
- PMID: 38943078
- PMCID: PMC11214226
- DOI: 10.1186/s12879-024-09494-8
Imbalanced IL10/TGF-β production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis
Abstract
Background: Human T-cell lymphotropic virus type 1 (HTLV-1), also denominated Human T-cell leukemia virus-1, induces immune activation and secretion of proinflammatory cytokines, especially in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Regulatory T lymphocytes (Tregs) may control of inflammation through the production of regulatory cytokines, including IL10 and TGF-β. In this study we determined the frequencies of CD4 + and CD8 + Tregs in a HAM/TSP population, compared to asymptomatic carriers and uninfected individuals, as well as investigated the profiles of regulatory and inflammatory cytokines.
Methods: Asymptomatic HTLV-1 carriers and HAM/TSP patients were matched by sex and age. The frequencies of IL10- and/or TGF-β-producing Tregs were quantified by flow cytometry. Real-time reverse transcription polymerase chain reaction (RT-PCR) was used to quantify HTLV-1 proviral load and the mRNA expression of cytokines and cellular receptors in peripheral blood mononuclear cells.
Results: Total frequencies of CD4 + Tregs, as well as the IL10-producing CD4 + and CD8 + Treg subsets, were statistically higher in patients with HAM/TSP compared to asymptomatic HTLV-1-infected individuals. In addition, a positive correlation was found between the frequency of CD4 + IL10 + Tregs and proviral load in the HAM/TSP patients evaluated. A positive correlation was also observed between gene expression of proinflammatory versus regulatory cytokines only in HAM / TSP group.
Conclusions: A higher frequencies of IL10-producing Tregs were identified in patients with HAM/TSP. Imbalanced production of IL10 in relation to TGF-β may contribute to the increased inflammatory response characteristically seen in HAM/TSP patients.
Keywords: HTLV-1; HTLV-associated myelopathy; IL10; Regulatory T lymphocytes; TGF-β.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.J Immunol. 2004 Feb 1;172(3):1735-43. doi: 10.4049/jimmunol.172.3.1735. J Immunol. 2004. PMID: 14734756
-
Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.Appl Biochem Biotechnol. 2017 Aug;182(4):1403-1414. doi: 10.1007/s12010-017-2406-7. Epub 2017 Jan 18. Appl Biochem Biotechnol. 2017. PMID: 28101786
-
The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.J Neurovirol. 2020 Jun;26(3):338-346. doi: 10.1007/s13365-020-00832-5. Epub 2020 Apr 8. J Neurovirol. 2020. PMID: 32270468
-
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.Inflamm Allergy Drug Targets. 2008 Jun;7(2):98-107. doi: 10.2174/187152808785107642. Inflamm Allergy Drug Targets. 2008. PMID: 18691139 Review.
-
[Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].Rev Neurol. 2009 Feb 1-15;48(3):147-55. Rev Neurol. 2009. PMID: 19206063 Review. Spanish.
Cited by
-
Coincidental Coexistence of Human T-lymphotropic Virus Type 1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis and Myasthenia Gravis in a Patient With Chronic HTLV-1 Infection: A Case Report.Cureus. 2025 Jul 17;17(7):e88163. doi: 10.7759/cureus.88163. eCollection 2025 Jul. Cureus. 2025. PMID: 40821191 Free PMC article.
-
Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders.Clin Rev Allergy Immunol. 2025 Feb 11;68(1):14. doi: 10.1007/s12016-025-09022-9. Clin Rev Allergy Immunol. 2025. PMID: 39932617 Review.
References
MeSH terms
Substances
Grants and funding
- grants 9600141/National Foundation for the Development of Private Higher Education
- grants 9600140/National Foundation for the Development of Private Higher Education
- grants 473667/2012-6/Conselho Nacional de Desenvolvimento Científico e Tecnológico
- grants 308167/2021-0/Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Call 014/2013, PET0030/2013/Fundação de Amparo à Pesquisa do Estado da Bahia,Brazil
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous